some we Thanks and Christie. going who you to everyone. us to are premium the company, for context why growth a you, you up. Thank afternoon call that on give tell we joining Good today. we're back are, Today,
platform Over the to the the course evolve manufacturers, into of healthcare: affordability now XXXX, providers, patients, OptimizeRx a continued leading and and digital enabling in hospitals, all to adherence pharmaceutical key players payers. health
with point patients, at with exclusivity We've the We our relevant information some care deliver of built systems. physicians over of and EHR and are to have meaningful digital become important being the helping years E-Prescribe measure clinical our platform leading when decisions clients reach made. into a integrating physician communication by in
with work and meaningful XX than we a in and client companies this also partners siloed believe of invested space. looking other deeply our XX We top all and enter businesses in need created We've become entrenched early have clients, services. for base. multiple this to has to with entry barrier which the were others more our pharmaceutical We of our
to we via starting contracts. us, Given enterprise SaaS in true shift a the and more trust clients our revenue engagements are to recurring model have
greater the point-of-care tremendous there's sit measurable. effective, in growing one health We client connectivity, technology; segments transparent, is a squarely and the fastest where which in also demand for of communications, the
client. year this market. have larger services. also multibillion-dollar our market This, We engagement today driven Lastly, each now coupled and land than much by our expand our with patient ago with is new with a ability to a expansion, addressable addressable
the today, growth quarter experienced we issued major returned in from following you two we QX merger. release in setback saw our a press with to earlier As the undergoing clients
generated was the still original growth it we for expectations. and quarter year, double-digit our While below
We our believe much of to and we our greater revenue innovative key due are now this given client disruption, products the base streams acquisitions. diversification type and of past
to the in revenue coming of estimated top continue growth expect on also XXXX, an We layering some million already lost $X into of trajectory. strong
on excitement based having confidence better areas. and a My few in XXXX is for visibility important also
partner solution opportunities hundreds of We on are focused set. with the existing focusing laser millions preferred health with clients of our on revenue short-term in the becoming by digital our dollars
expanding a We closing this whitespace bit. deals will our into by enterprise clients. and little do this get will in around tactically current into Steve the
We stakeholders. meaningful partners, source continue our solutions to helping for a additional with innovation develop and them our by of collective be revenue
as from our Miriam great well point-of-care. as getting into We founded things key are Innovation get bit will little partnerships our later. newly some to more, expand a Lab, within reach that
support solve growth that help We with. to doctor technology platform and we discussion. now we the have our together working the be protect that we age, strive work class be digital best digital we scalable and and so in of to Today, live the everyone secure can the when both time place an to health so are appropriate patient at and there issues,
market. our a our innovate revenue clients, recurring focus of us in expect to a and changes deeper the to keep with ultimately, more this stream, We in benefit predictable ability key ahead a opportunities yield partners the to of way and with relationships
payers, physicians, designed and to emerging Our trends between has particularly, and industry in been the address communication gap the our to close patients. platform further pharma,
as manage knew especially increasing important, patient well the onto value being on way as the increasingly specialty with coming patients. to pharma we placed become health. doctors the as tools patients, and transparency, the comes their has more medications of and lower a payers, with wanting for field the consumer outcomes choice, this cost gap engaged Along this in Closing market, and for for better health,
increasingly allows deal much from clients to and us streams larger evident of which SaaS coming our address engagements. average needs platform OptimizeRx, potential For has existing enterprise stickier XXXX. size, $XXX,XXX in a to in These growth revenue of $XXX,XXX increased into of the more group and has XXXX around integrated enterprise expand This than clients. recurring the our approach become deals within include
a pipeline Steve like us the us followed I'd by call the return over now, financial technology segments, then then into and Doug to products. to up details provide to will the client wrap hand our and to quarter Doug? to year. and For view give it open innovation the and on Miriam, up I'll questions. update product who we'll our your will of Afterward,